Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
OtherBASIC SCIENCE INVESTIGATIONS

Noninternalizing Monoclonal Antibodies Are Suitable Candidates for 125I Radioimmunotherapy of Small-Volume Peritoneal Carcinomatosis

Lore Santoro, Samir Boutaleb, Véronique Garambois, Caroline Bascoul-Mollevi, Vincent Boudousq, Pierre-Olivier Kotzki, Monique Pèlegrin, Isabelle Navarro-Teulon, André Pèlegrin and Jean-Pierre Pouget
Journal of Nuclear Medicine December 2009, 50 (12) 2033-2041; DOI: https://doi.org/10.2967/jnumed.109.066993
Lore Santoro
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Samir Boutaleb
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Véronique Garambois
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Caroline Bascoul-Mollevi
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Vincent Boudousq
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pierre-Olivier Kotzki
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Monique Pèlegrin
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Isabelle Navarro-Teulon
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
André Pèlegrin
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jean-Pierre Pouget
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Additional Files
  • FIGURE 1. 
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 1. 

    Tumor growth and bioluminescence calibration curves. (A) Swiss nude mice bearing 1- to 2-mm xenograft A-431 tumor nodules were followed by bioluminescence imaging. Flow cytometry analysis (inset) indicated similar levels of expression of EGFR and CEA receptors at surface of A-431 cells. (B) In vivo relationship between bioluminescence signal and mean tumor weight per mouse. Ph/s = photons/s.

  • FIGURE 2. 
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 2. 

    Swiss nude mice bearing intraperitoneal A-431 tumor cell xenografts were injected twice with 37 MBq of 125I-mAbs (370 MBq/mg) or with unlabeled mAbs (100 μg). (A) Noninternalizing 35A7 mAbs. (B) Internalizing m225 mAbs. (C) Irrelevant PX mAbs. Untreated controls were injected with NaCl. Tumor growth was followed by bioluminescence imaging. Corresponding mean tumor weights were next calculated using calibration curve reported in Figure 1B, and they are shown as function of time in A, B, C, respectively.

  • FIGURE 3. 
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 3. 

    Swiss nude mice bearing intraperitoneal A-431 tumor cell xenografts were intravenously injected twice with 37 MBq of 125I-mAbs (370 MBq/mg) or with unlabeled mAb (100 μg). (A) Noninternalizing 35A7 mAbs. (B) Internalizing m225 mAbs. (C) Irrelevant PX mAb. Survival rates were estimated using Kaplan–Meier method. Mice were sacrificed when bioluminescence signal reached 4.5 × 107 photons/s. Censored mice are indicated on graph by vertical bars.

  • FIGURE 4. 
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 4. 

    Biodistribution. Swiss nude mice bearing intraperitoneal A-431 tumor cell xenografts were intravenously injected twice with solution containing specific 125I-mAbs or irrelevant131I-PX. %IA/g was determined in healthy organs and tumors. (A) Noninternalizing 125I-mAbs. (B) Internalizing 125I-mAbs. Four mice were analyzed at each time point.

  • FIGURE 5. 
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 5. 

    Uptake of radioactivity. Uptake of radioactivity per tissue (becquerel) was determined using values obtained during biodistribution experiments (Fig. 4). (A) Noninternalizing 125I-mAbs. (B) Internalizing 125I-mAbs.

  • FIGURE 6. 
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 6. 

    MIRD dose calculation. From Figure 5, total cumulative decays per tissue, Ã, was calculated by measuring area under each curve. Ã was next multiplied by 19.483 keV, corresponding to mean energy delivered at each 125I decay.

Additional Files

  • Figures
  • Supplemental Data

    Files in this Data Supplement:

    • Supplemental Figures
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 50 (12)
Journal of Nuclear Medicine
Vol. 50, Issue 12
December 2009
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Noninternalizing Monoclonal Antibodies Are Suitable Candidates for 125I Radioimmunotherapy of Small-Volume Peritoneal Carcinomatosis
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Noninternalizing Monoclonal Antibodies Are Suitable Candidates for 125I Radioimmunotherapy of Small-Volume Peritoneal Carcinomatosis
Lore Santoro, Samir Boutaleb, Véronique Garambois, Caroline Bascoul-Mollevi, Vincent Boudousq, Pierre-Olivier Kotzki, Monique Pèlegrin, Isabelle Navarro-Teulon, André Pèlegrin, Jean-Pierre Pouget
Journal of Nuclear Medicine Dec 2009, 50 (12) 2033-2041; DOI: 10.2967/jnumed.109.066993

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Noninternalizing Monoclonal Antibodies Are Suitable Candidates for 125I Radioimmunotherapy of Small-Volume Peritoneal Carcinomatosis
Lore Santoro, Samir Boutaleb, Véronique Garambois, Caroline Bascoul-Mollevi, Vincent Boudousq, Pierre-Olivier Kotzki, Monique Pèlegrin, Isabelle Navarro-Teulon, André Pèlegrin, Jean-Pierre Pouget
Journal of Nuclear Medicine Dec 2009, 50 (12) 2033-2041; DOI: 10.2967/jnumed.109.066993
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF

Related Articles

  • This Month in JNM
  • PubMed
  • Google Scholar

Cited By...

  • Marshalling the Potential of Auger Electron Radiopharmaceutical Therapy
  • Imaging DNA Damage Repair In Vivo After 177Lu-DOTATATE Therapy
  • Drugs That Modify Cholesterol Metabolism Alter the p38/JNK-Mediated Targeted and Nontargeted Response to Alpha and Auger Radioimmunotherapy
  • Radiolabeled Antibodies Against Mullerian-Inhibiting Substance Receptor, Type II: New Tools for a Theranostic Approach in Ovarian Cancer
  • Development of 124I Immuno-PET Targeting Tumor Vascular TEM1/Endosialin
  • Molecular Radiotherapy Using Cleavable Radioimmunoconjugates That Target EGFR and {gamma}H2AX
  • Experimental Radionuclide Therapy of HER2-Expressing Xenografts Using Two-Step Targeting Nuclisome Particles
  • Antibody-Radionuclide Conjugates for Cancer Therapy: Historical Considerations and New Trends
  • Brief Intraperitoneal Radioimmunotherapy of Small Peritoneal Carcinomatosis Using High Activities of Noninternalizing 125I-Labeled Monoclonal Antibodies
  • Google Scholar

More in this TOC Section

  • PET/MRI of Hypoxic Atherosclerosis Using 64Cu-ATSM in a Rabbit Model
  • Tumor Uptake of Anti-CD20 Fabs Depends on Tumor Perfusion
  • How Sensitive Is the Upper Gastrointestinal Tract to 90Y Radioembolization? A Histologic and Dosimetric Analysis in a Porcine Model
Show more Basic Science Investigations

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire